We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JELD icon
926
JELD-WEN Holding
JELD
$168M
$591K ﹤0.01%
+26,173
New +$536K
PLOW icon
927
Douglas Dynamics
PLOW
$980M
$589K ﹤0.01%
+17,212
New +$636K
PARA
928
DELISTED
Paramount Global Class B
PARA
$588K ﹤0.01%
+20,983
New +$562K
BR icon
929
Broadridge
BR
$19.6B
$587K ﹤0.01%
+4,448
New +$595K
GLNG icon
930
Golar LNG
GLNG
$5.19B
$586K ﹤0.01%
+96,822
New +$866K
ABCB icon
931
Ameris Bancorp
ABCB
$5.92B
$585K ﹤0.01%
25,652
-29,564
-54% -$695K
ENTA icon
932
Enanta Pharmaceuticals
ENTA
$386M
$584K ﹤0.01%
12,761
+3,255
+34% +$158K
AU icon
933
AngloGold Ashanti
AU
$48.9B
$583K ﹤0.01%
+22,123
New +$662K
TSEM icon
934
Tower Semiconductor
TSEM
$28.3B
$583K ﹤0.01%
+31,983
New +$645K
BLMN icon
935
Bloomin' Brands
BLMN
$950M
$575K ﹤0.01%
37,645
-161,821
-81% -$2.09M
SBH icon
936
Sally Beauty Holdings
SBH
$1.59B
$574K ﹤0.01%
66,008
-185,470
-74% -$2.23M
APPF icon
937
AppFolio
APPF
$7.16B
$569K ﹤0.01%
+4,011
New +$618K
MRTN icon
938
Marten Transport
MRTN
$1.19B
$569K ﹤0.01%
+34,857
New +$616K
RACE icon
939
Ferrari
RACE
$72.2B
$568K ﹤0.01%
+3,082
New +$573K
ALXN
940
DELISTED
Alexion Pharmaceuticals
ALXN
$568K ﹤0.01%
4,965
-152,766
-97% -$16.5M
MYGN icon
941
Myriad Genetics
MYGN
$307M
$566K ﹤0.01%
43,441
-65,999
-60% -$835K
VRSN icon
942
VeriSign
VRSN
$26.5B
$566K ﹤0.01%
2,761
-31,351
-92% -$6.48M
ACM icon
943
Aecom
ACM
$8.64B
$561K ﹤0.01%
+13,413
New +$511K
SAVE
944
DELISTED
Spirit Airlines, Inc.
SAVE
$553K ﹤0.01%
+34,328
New +$591K
FTI icon
945
TechnipFMC
FTI
$29.2B
$547K ﹤0.01%
116,673
-691,242
-86% -$3.88M
OLN icon
946
Olin
OLN
$2.19B
$544K ﹤0.01%
+43,942
New +$508K
STLA icon
947
Stellantis
STLA
$20.6B
$544K ﹤0.01%
+44,504
New +$495K
SIG icon
948
Signet Jewelers
SIG
$3.67B
$542K ﹤0.01%
+28,951
New +$421K
MFC icon
949
Manulife Financial
MFC
$73.2B
$535K ﹤0.01%
38,600
-251,057
-87% -$3.59M
SU icon
950
Suncor Energy
SU
$74B
$535K ﹤0.01%
44,000
+17,000
+63% +$266K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.